The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China.
J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2639-e2646. doi: 10.1210/clinem/dgab171.
Prepregnancy overweight/obesity (OWO) and isolated maternal hypothyroxinemia (IMH) may increase the risk of macrosomia, but little is known about their potential combined effect on macrosomia.
The aim of this study was to assess whether prepregnancy OWO and first-trimester IMH have a synergistic effect on the risk of macrosomia.
A large prospective cohort study in a Chinese population from January 2016 to December 2018 in a tertiary care center. In total, 34 930 pregnant women were included. The main outcome measure was macrosomia.
A total of 34 930 participants comprising IMH and euthyroid cases was included in this study. Prepregnancy OWO and first-trimester IMH were independently associated with an increased risk of macrosomia (adjusted odds ratio [OR] 2.48, 95% CI 2.22, 2.78, and adjusted OR 1.65, 95% CI 1.34, 2.01, respectively). The coexistence of prepregnancy OWO and IMH was associated with macrosomia, with an adjusted OR of 5.26 (95% CI 3.9, 7.0) compared with pregnant women without either condition. The additive interaction between prepregnancy OWO and IMH was found to be significant with regard to macrosomia.
Prepregnancy OWO and IMH in the first trimester may synergistically increase the risk of macrosomia.
孕前超重/肥胖(OWO)和孤立性母体甲状腺功能减退症(IMH)可能增加巨大儿的风险,但对于它们对巨大儿的潜在联合作用知之甚少。
本研究旨在评估孕前 OWO 和孕早期 IMH 是否对巨大儿风险有协同作用。
这是一项 2016 年 1 月至 2018 年 12 月在中国一家三级保健中心进行的大型前瞻性队列研究。共纳入 34930 名孕妇。主要结局指标为巨大儿。
本研究共纳入 34930 名包括 IMH 和甲状腺功能正常病例的参与者。孕前 OWO 和孕早期 IMH 与巨大儿风险增加独立相关(调整后的优势比[OR]2.48,95%CI2.22,2.78 和调整后的 OR1.65,95%CI1.34,2.01)。孕前 OWO 和 IMH 并存与巨大儿相关,与无任何一种情况的孕妇相比,调整后的 OR 为 5.26(95%CI3.9,7.0)。孕前 OWO 和 IMH 之间对巨大儿的相加交互作用具有统计学意义。
孕前 OWO 和孕早期 IMH 可能协同增加巨大儿的风险。